Cite

HARVARD Citation

    Tsimberidou, A. et al. (n.d.). 293 Resultsof the first-in-human clinical trial with personalized multi-target adoptive cell therapy (ACTolog IMA101). Journal for immunotherapy of cancer. p. A179. [Online]. 
  
Back to record